688581 logo

Hangzhou AGS MedTech Co., Ltd. Stock Price

SHSE:688581 Community·CN¥4.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

688581 Share Price Performance

CN¥53.74
-5.05 (-8.59%)
CN¥53.74
-5.05 (-8.59%)
Price CN¥53.74

688581 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet average dividend payer.

0 Risks
1 Reward

Hangzhou AGS MedTech Co., Ltd. Key Details

CN¥597.2m

Revenue

CN¥0

Cost of Revenue

CN¥597.2m

Gross Profit

CN¥374.4m

Other Expenses

CN¥222.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 23, 2026
2.76
100.00%
37.31%
0.1%
View Full Analysis

About 688581

Founded
2010
Employees
856
CEO
Cheng Zhang
WebsiteView website
www.bioags.com

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generators, endoscopic C02 regulation units, endoscopic water pumps, single use electrosurgical knife combination, and bipolar coagulation forceps; ERCP products, such as disposable guide wires, disposable stone extraction baskets, stone retrieval balloons, and sphincterotome; and disposable endoscope cleaning brushes. The company was incorporated in 2010 and is headquartered in Hangzhou, China.

Recent 688581 News & Updates

Recent updates

No updates